Arpita Vyas
Papers
1
Total Citations
23
H-Index
1
About
Arpita Vyas is a pioneering researcher at the intersection of genetic engineering and clinical translation, best known for her seminal work on CRISPR/Cas9 technology. Her most-cited paper, “Clustered Regularly Interspaced Short Palindromic Repeats/Cas9 Genetic Engineering: Robotic Genetic Surgery” (2015, 23 citations), introduced a powerful conceptual framework that reimagines CRISPR/Cas9 as a form of “robotic genetic surgery.” In this work, Vyas elegantly articulated how programmable sgRNA sequences and Cas9 nucleases function as precision molecular tools, leveraging the bacterial immune system to introduce targeted double-strand breaks in DNA. Her major contribution lies in bridging fundamental CRISPR biology with pragmatic clinical applications, emphasizing the technology’s potential for therapeutic gene editing. By framing genetic engineering as a surgical discipline, Vyas helped demystify complex molecular mechanisms for a broader biomedical audience. Her research focuses on advancing CRISPR-based therapies, improving delivery systems, and addressing off-target effects to ensure clinical safety. Though early in her career, Vyas’s work has already influenced discussions on the ethical and translational dimensions of gene editing. Her 2015 paper remains a foundational reference for students and researchers exploring CRISPR’s therapeutic promise, cementing her role as a thoughtful innovator in the rapidly evolving field of genetic medicine.
Research Focus
Key Achievements
Top Papers
- 1